A detailed history of Manning & Napier Group, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Manning & Napier Group, LLC holds 154,031 shares of BAX stock, worth $5.55 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
154,031
Previous 169,008 8.86%
Holding current value
$5.55 Million
Previous $6.53 Million 0.75%
% of portfolio
0.08%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$37.88 - $43.77 $567,328 - $655,543
-14,977 Reduced 8.86%
154,031 $6.58 Million
Q4 2023

Jan 19, 2024

SELL
$31.71 - $38.95 $856,043 - $1.05 Million
-26,996 Reduced 13.77%
169,008 $6.53 Million
Q3 2023

Oct 20, 2023

SELL
$37.32 - $49.29 $184,286 - $243,394
-4,938 Reduced 2.46%
196,004 $7.4 Million
Q2 2023

Jul 26, 2023

BUY
$39.98 - $47.68 $2.65 Million - $3.16 Million
66,343 Added 49.29%
200,942 $9.15 Million
Q1 2023

Apr 17, 2023

SELL
$37.58 - $52.57 $21,495 - $30,070
-572 Reduced 0.42%
134,599 $5.46 Million
Q4 2022

Jan 26, 2023

SELL
$49.7 - $57.71 $27,086 - $31,451
-545 Reduced 0.4%
135,171 $0
Q3 2022

Oct 18, 2022

SELL
$53.86 - $66.8 $129,479 - $160,587
-2,404 Reduced 1.74%
135,716 $7.31 Million
Q2 2022

Jul 12, 2022

BUY
$63.83 - $80.0 $8.82 Million - $11 Million
138,120 New
138,120 $8.87 Million
Q1 2020

Apr 13, 2020

SELL
$71.57 - $93.3 $214,709 - $279,900
-3,000 Closed
0 $0
Q1 2019

Apr 10, 2019

BUY
$64.48 - $81.31 $193,440 - $243,930
3,000 New
3,000 $243,000
Q4 2018

Jan 24, 2019

SELL
$61.45 - $77.8 $184,350 - $233,400
-3,000 Closed
0 $0
Q3 2018

Oct 10, 2018

BUY
$70.71 - $77.75 $212,129 - $233,250
3,000 New
3,000 $231,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.2B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Manning & Napier Group, LLC Portfolio

Follow Manning & Napier Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.